55213.1 IP-LS

Résumé

New and efficient synthesis of Noroxymorphone - the key intermediate of the synthesis of Opioid-Antagonists

Textes supplémentaires

Abstract

We aim to develop a new and efficient synthesis of Noroxymorphone - the key intermediate of the synthesis of opioid antagonists used as active pharmaceutical ingredients (i.e. Naloxone, Naltrexone) for the treatment ofopioid addicts and as opioid antagonists in opioid based medication.

Participants

Roman Gerber

Wirtschaftspartner

rgerber@azad.ch

AZAD Pharma AG CHE-110.166.192 Roman Gerber Durachstrasse 15 8200 Schaffhausen SH CH

Christian Frech Nabold

Kontaktperson

christian.frech@zhaw.ch

ZHAW Christian Frech Nabold Einsiedlerstrasse 31 8820 Wädenswil ZH CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: In Bearbeitung
Type de projet: Forschungsprojekt
Date de début: 2021-10-31
Date de fin: 2024-04-30
Coûts totaux approuvés: CHF 866298.60
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T410 Pharmaceuticals and related technologies 100.0%